FastBack Bio Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
FastBack Bio General Information
Description
Developer of a cell and gene therapy platform designed to modulate T cell responses and endow CAR-T cells with several beneficial characteristics. The company's platform develops M83-based CAR-T cells that are resistant to exhaustion in vitro and exhibit enhanced metabolism that may be beneficial in the tumor microenvironment, enabling healthcare researchers to develop T cell-based therapeutics and gene therapies to cure cancer.
Contact Information
Website
www.fastback.bioCorporate Office
- 9131 Anson Way
- Suite 101
- Raleigh, NC 27615
- United States
Corporate Office
- 9131 Anson Way
- Suite 101
- Raleigh, NC 27615
- United States
FastBack Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 02-Oct-2026 | Completed | Out of Business | |||
| 1. Seed Round | 16-Nov-2020 | Completed | Startup |
FastBack Bio FAQs
-
When was FastBack Bio founded?
FastBack Bio was founded in 2020.
-
Where is FastBack Bio headquartered?
FastBack Bio is headquartered in Raleigh, NC.
-
What industry is FastBack Bio in?
FastBack Bio’s primary industry is Drug Discovery.
-
Is FastBack Bio a private or public company?
FastBack Bio is a Private company.
-
What is FastBack Bio’s current revenue?
The current revenue for FastBack Bio is .
-
How much funding has FastBack Bio raised over time?
FastBack Bio has raised $1.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process